What are you searching for…

New Webinar: Introducing RESIPHER brought to you by Baker Ruskinn

09-07-2020

New Webinar: Introducing RESIPHER brought to you by Baker Ruskinn

Wednesday 15th July, 1:00pm - 2:00pm EDT

Presented by Walker Inman, Ph.D. and Krista Rantanen, Ph.D. Dr. Inman is the co-founder and CEO of Lucid Scientific, the developer of the RESIPHER real-time metabolic analysis platform and Dr. Krista is a Physoxia ambassador, hypoxia enthusiast and cancer researcher. Director of Scientific Applications, Baker Ruskinn.

Register Now

Becton, Dickinson & Company launch antigen test

07-07-2020

Becton, Dickinson & Company launch antigen test

BDandCo have announced the launch of their new portable, rapid antigen test. The test is able to detect the SARS-CoV-2 antigen within 15 minutes. The company will begin shipping the tests this week. Find out more for yourself.

Vaxart’s stable tablet vaccine

06-07-2020

Vaxart’s stable tablet vaccine

Vaxart’s room temperature stable tablet vaccine has been selected for a non-human primate challenge study (NHP). The purpose of the study is to commit to the delivery of 300 million vaccine doses by 2021. Find out more.

06-07-2020

Supporting Science in a world of COVID-19, 6th July 2020!

This week's round up during the COVID-19 pandemic!

Read More »

Chongqing Medical University study asymptomatic cases of COVID-19

05-07-2020

Chongqing Medical University study asymptomatic cases of COVID-19

Researchers from Chongqing University have found that the median viral shredding among asymptomatic cases of COVID-19 was 19 days versus 14 days among patients with mild symptoms. Find out more.

Swiss Biotech’s candidate due to enter Phase II trials

03-07-2020

Swiss Biotech’s candidate due to enter Phase II trials

Axon have said that Swiss-based Bachem will help scale up its COVID-19 vaccine. The Swiss Biotech’s candidate (COVIDAX) claims it can be used to protect a broader range of people other than candidates. Find out more for yourself.

University of California develop nanosponges

30-06-2020

University of California develop nanosponges

These nanosponges are able to attract and neutralize SARS-CoV-2 in cell culture, therefore causing the virus to lose its ability to hijack host cells and reproduce. Find out more.

29-06-2020

Supporting Science in a world of COVID-19, 29th June 2020!

This week's round up during the COVID-19 pandemic! 

Read More »

Commercialization of vaccine

29-06-2020

Commercialization of vaccine

Catalent Pharmaceutical Services, based in Anagni, Italy are prepared for around the clock manufacturing schedules, in order to complete the vial filling and packaging services for the commercialization of the University of Oxford & AstraZeneca’s vaccine candidate. Find out more.

The importance of interdisciplinary groups

25-06-2020

The importance of interdisciplinary groups

The Daily Biologist believes that not enough emphasis is placed on interdisciplinary groups, despite it being a highly valued component of industry settings. What do you think? Find out more here.

23-06-2020

Supporting Science in a world of COVID-19, 23rd June 2020!

This week's round up during the COVID-19 pandemic! 

Read More »

Ask us a question? Get in touch

Contact Us